Bladder Cancer Symptoms, Diagnosis, and Treatment Explained

Introduction

Bladder cancer is a serious condition that affects thousands of people each year. It occurs when abnormal cells in the bladder grow uncontrollably, forming tumors that can interfere with the bladder’s normal function. The bladder, a hollow organ located in the lower abdomen, stores urine before it is expelled from the body. Bladder cancer is one of the most common cancers in the United States, particularly among older adults. This article provides a comprehensive overview of bladder cancer, including its risk factors, symptoms, diagnostic tests, treatment options, and ways patients can manage their symptoms at home. By understanding bladder cancer, patients can make informed decisions about their health and work closely with healthcare providers to develop personalized treatment plans.

What is Bladder Cancer?

Bladder cancer begins in the cells of the bladder and can spread to other parts of the body. This article will explore the risk factors, symptoms, diagnostic tests, treatments, and home management strategies for bladder cancer.

Understanding Bladder Cancer

Bladder cancer occurs when the cells lining the bladder begin to grow abnormally, forming tumors that can be either benign (non-cancerous) or malignant (cancerous). Malignant tumors can invade nearby tissues and spread to other parts of the body, a process known as metastasis. The most common type of bladder cancer is urothelial carcinoma, which starts in the cells lining the bladder. Less common types include squamous cell carcinoma and adenocarcinoma.

Bladder cancer progresses in stages, beginning with non-invasive cancer confined to the bladder lining and potentially advancing to more invasive stages where it spreads to the bladder muscle or beyond. Early detection is crucial, as bladder cancer is more treatable in its early stages. According to the American Cancer Society, approximately 81,000 new cases of bladder cancer are diagnosed in the U.S. each year, with men being more likely to develop the disease than women. The five-year survival rate for bladder cancer varies by stage, but early-stage bladder cancer generally has a relatively high survival rate.

Bladder Cancer Risk Factors

Lifestyle Risk Factors

Certain lifestyle choices can significantly increase the risk of bladder cancer. Smoking is the most prominent risk factor, as it exposes the bladder to harmful chemicals that are filtered out of the bloodstream and concentrated in the urine. Smokers are three times more likely to develop bladder cancer than non-smokers. Occupational exposure to chemicals, particularly in industries such as rubber, leather, textiles, and printing, also raises the risk. Workers in these fields may be exposed to carcinogens that accumulate in the bladder over time. Chronic bladder irritation or infections, such as those caused by long-term catheter use or recurrent urinary tract infections (UTIs), may also elevate the risk of developing bladder cancer.

Medical Risk Factors

Certain medical conditions and treatments can also increase the likelihood of bladder cancer. Individuals with a history of bladder cancer are at a higher risk of recurrence. Additionally, those who have undergone radiation therapy to the pelvic area for other cancers, such as prostate or cervical cancer, may face an increased risk. Some chemotherapy drugs, particularly cyclophosphamide, have been linked to a higher risk of bladder cancer. Chronic bladder inflammation, such as that caused by interstitial cystitis, can also heighten the risk of developing bladder cancer.

Genetic and Age-Related Risk Factors

Genetics and age play important roles in the development of bladder cancer. While bladder cancer is not typically inherited, individuals with a family history of the disease may have a higher risk. Certain genetic mutations, such as those affecting the TP53 or RB1 genes, can increase susceptibility. Age is another significant factor, as the risk of bladder cancer rises with age. Most cases are diagnosed in individuals over 55, with the average age at diagnosis being 73. Men are more likely to develop bladder cancer than women, although the reasons for this gender disparity are not fully understood.

Bladder Cancer Symptoms

Hematuria (Blood in the Urine)

Hematuria, or blood in the urine, is the most common symptom of bladder cancer, occurring in about 85% of patients. It can be visible to the naked eye (gross hematuria) or only detectable under a microscope (microscopic hematuria). Hematuria often occurs without pain and may come and go, leading some patients to delay seeking medical attention. Bladder cancer causes hematuria because tumors in the bladder lining can bleed into the urine. As the cancer progresses, the bleeding may become more frequent or severe. However, hematuria can also be caused by other conditions, such as UTIs or kidney stones, so further diagnostic testing is essential to confirm bladder cancer.

Frequent Urination

Frequent urination, or the need to urinate more often than usual, affects about 30% of bladder cancer patients. This symptom is more common in the early stages when tumors irritate the bladder lining. The bladder may become more sensitive, leading to the sensation of needing to urinate frequently, even when it is not full. Bladder cancer can disrupt normal bladder function, which is responsible for storing urine. Other conditions, such as overactive bladder or UTIs, can also cause frequent urination, so it is important to consult a healthcare provider for an accurate diagnosis.

Painful Urination (Dysuria)

Painful urination, or dysuria, occurs in about 20% of bladder cancer patients. It is often described as a burning or stinging sensation during urination. Bladder cancer can cause painful urination when tumors invade the bladder wall or irritate the bladder lining. In some cases, the pain may result from secondary infections or inflammation caused by the cancer. Like other urinary symptoms, painful urination can also be caused by non-cancerous conditions, such as UTIs or sexually transmitted infections, making further testing essential if this symptom occurs.

Urgency to Urinate

Urgency to urinate, or the sudden and intense need to urinate, affects about 25% of bladder cancer patients. This symptom is often associated with early-stage bladder cancer, where tumors irritate the bladder lining, causing the bladder to contract more frequently. Patients may feel the need to urinate urgently, even if the bladder is not full. Urgency can also be a sign of other bladder conditions, such as overactive bladder or interstitial cystitis, so it is important to seek medical advice if this symptom persists.

Back Pain

Back pain, particularly in the lower back, occurs in about 10% of bladder cancer patients, especially in more advanced stages. This symptom can develop when bladder cancer spreads to nearby tissues or organs, such as the kidneys or bones. The pain may be constant or intermittent and can range from mild discomfort to severe pain. Back pain can also be caused by other conditions, such as kidney stones or musculoskeletal issues, so it is important to consult a healthcare provider for a thorough evaluation.

Pelvic Pain

Pelvic pain is reported by approximately 15% of bladder cancer patients, particularly in advanced stages. This pain is often felt in the lower abdomen or pelvic region and may be caused by the tumor pressing on surrounding tissues or organs. As bladder cancer progresses, it can invade nearby structures, leading to discomfort or pain in the pelvic area. Pelvic pain can also be caused by other conditions, such as pelvic inflammatory disease or endometriosis, so further testing is necessary to determine the cause.

Unexplained Weight Loss

Unexplained weight loss occurs in about 10% of bladder cancer patients, particularly in advanced stages. This symptom may be due to the body’s response to the cancer, as well as the increased energy demands of the tumor. Weight loss can also occur if the cancer spreads to other organs, affecting their function. In some cases, patients may lose their appetite or experience nausea, further contributing to weight loss. Unexplained weight loss should always be evaluated by a healthcare provider, as it can be a sign of various medical conditions, including cancer.

Fatigue

Fatigue, or a persistent feeling of tiredness or lack of energy, affects about 20% of bladder cancer patients. This symptom can occur at any stage of the disease but is more common in advanced stages. Fatigue may be caused by the body’s response to the cancer, as well as the physical and emotional toll of the disease. In some cases, fatigue may be related to anemia, which can occur if the cancer causes chronic blood loss. Fatigue can also be caused by other factors, such as stress or sleep disturbances, so it is important to discuss this symptom with a healthcare provider.

Urinary Incontinence

Urinary incontinence, or the involuntary loss of urine, occurs in about 5% of bladder cancer patients. This symptom is more common in advanced stages, particularly if the cancer has spread to the muscles or nerves that control bladder function. Incontinence can range from occasional leakage to a complete inability to control urination. Bladder cancer can cause incontinence by disrupting the normal function of the bladder and surrounding structures. Other conditions, such as prostate issues or neurological disorders, can also cause incontinence, so further evaluation is necessary.

Bladder Irritation

Bladder irritation, including discomfort or a burning sensation in the bladder, affects about 15% of bladder cancer patients. This symptom is often caused by tumors irritating the bladder lining, leading to inflammation and discomfort. Bladder irritation can also be a sign of other conditions, such as UTIs or interstitial cystitis, so it is important to seek medical advice if this symptom occurs. In some cases, bladder irritation may be accompanied by other urinary symptoms, such as frequent urination or urgency.

Treatment Options for Bladder Cancer

Medications for Bladder Cancer

Mitomycin C

Mitomycin C is a chemotherapy drug that works by inhibiting the growth of cancer cells. It is commonly used to prevent tumor recurrence after bladder cancer surgery.

Administered directly into the bladder through a catheter (a method known as intravesical therapy), Mitomycin C is often given after a transurethral resection (TURBT) to reduce the risk of cancer returning. This treatment is typically used for non-muscle-invasive bladder cancer.

Patients generally experience a reduction in tumor recurrence over several months, but regular follow-up appointments are crucial to monitor for any signs of the cancer coming back.

Bacillus Calmette-Guérin (BCG)

BCG is an immunotherapy that uses a weakened strain of bacteria to stimulate the immune system to attack bladder cancer cells.

Like Mitomycin C, BCG is administered intravesically and is primarily used for non-muscle-invasive bladder cancer, particularly in high-risk cases. It is often the first-line treatment after TURBT.

Patients typically undergo multiple treatments over several weeks. BCG has been shown to significantly reduce the chances of cancer recurrence and progression.

Gemcitabine

Gemcitabine is a chemotherapy drug that disrupts the DNA of cancer cells, preventing them from growing and dividing.

It can be used intravesically for non-muscle-invasive bladder cancer or as systemic chemotherapy for more advanced cases. Often combined with cisplatin, it is used to treat muscle-invasive or metastatic bladder cancer.

Patients may experience tumor shrinkage and delayed disease progression, with results typically seen after several treatment cycles.

Cisplatin

Cisplatin is a platinum-based chemotherapy drug that damages the DNA of cancer cells, leading to their death.

It is commonly used in combination with other chemotherapy drugs for muscle-invasive or metastatic bladder cancer. Administered intravenously, cisplatin is part of systemic chemotherapy regimens.

Patients may see a reduction in tumor size and slower cancer progression. However, cisplatin can cause significant side effects, including kidney damage, so careful monitoring is required.

Doxorubicin

Doxorubicin interferes with the DNA of cancer cells, preventing them from multiplying.

It is sometimes used in combination with other chemotherapy drugs for advanced bladder cancer. Administered intravenously, it is typically reserved for cases where other treatments have not been effective.

Patients may experience tumor shrinkage and delayed disease progression, though side effects such as heart damage may limit its use.

Pembrolizumab

Pembrolizumab is an immunotherapy drug that blocks the PD-1 protein on immune cells, helping the immune system recognize and attack cancer cells.

It is used for advanced or metastatic bladder cancer, particularly in patients who are not candidates for chemotherapy or whose cancer has progressed. Pembrolizumab is administered intravenously.

Patients may see a reduction in tumor size and improved survival rates, though it may take several weeks to see the full effects.

Atezolizumab

Atezolizumab is an immunotherapy drug that targets the PD-L1 protein on cancer cells, helping the immune system attack the cancer.

It is used for advanced or metastatic bladder cancer, especially in patients who cannot tolerate chemotherapy. Administered intravenously, it is often used when other treatments have not been successful.

Patients may experience tumor shrinkage and slower cancer progression, though responses can vary.

Nivolumab

Nivolumab is an immunotherapy drug that blocks the PD-1 protein on immune cells, enhancing the body’s ability to fight cancer.

It is used for advanced bladder cancer, particularly when the cancer has progressed after chemotherapy. Administered intravenously, nivolumab can improve survival and reduce tumor size.

Patients may see benefits after several weeks of treatment.

Valrubicin

Valrubicin is a chemotherapy drug used for bladder cancer that has not responded to BCG therapy.

Administered intravesically, valrubicin is typically used for non-muscle-invasive bladder cancer when surgery is not an option.

Patients may experience tumor size reduction and delayed disease progression, though responses can vary.

Docetaxel

Docetaxel is a chemotherapy drug that disrupts the growth of cancer cells.

It is sometimes used in combination with other chemotherapy drugs for advanced bladder cancer. Administered intravenously, it is typically reserved for cases where other treatments have failed.

Patients may experience tumor shrinkage and delayed disease progression, though side effects such as low blood cell counts may occur.

Procedures for Bladder Cancer Treatment

Transurethral Resection (TURBT)

Transurethral resection of bladder tumor (TURBT) is a surgical procedure used to remove bladder tumors through the urethra.

TURBT is the first-line treatment for non-muscle-invasive bladder cancer. Using a cystoscope, a thin tube with a camera and surgical tools, the tumor is removed without the need for external incisions.

Patients can expect the tumor to be removed, often followed by intravesical therapy to reduce the risk of recurrence. Recovery is usually quick, but follow-up is necessary to monitor for any signs of the cancer returning.

Cystectomy

Cystectomy is the surgical removal of the bladder, typically used for muscle-invasive bladder cancer or when other treatments have not been effective.

Cystectomy can be partial (removal of part of the bladder) or radical (removal of the entire bladder). It is often recommended for muscle-invasive bladder cancer or high-risk non-muscle-invasive cancer that has not responded to other treatments. In some cases, nearby organs may also be removed.

While cystectomy significantly reduces the risk of cancer recurrence, it is a major surgery and may involve long-term lifestyle changes, such as the need for urinary diversion.

Urinary Diversion

Urinary diversion is a surgical procedure that creates a new way for urine to exit the body after the bladder has been removed.

Performed after a radical cystectomy, urinary diversion options include an ileal conduit (using a piece of the intestine to create a passage for urine) or a neobladder (creating a new bladder from intestinal tissue). The choice depends on the patient’s health and personal preferences.

Patients can expect to regain urinary function, though the method of urination will differ. Recovery can take several weeks, and patients will need to adapt to changes in their urinary system.

Improving Bladder Cancer Outcomes and Seeking Medical Help

While medical treatments are essential for managing bladder cancer, certain lifestyle changes can support overall health and potentially improve outcomes. Here are some home remedies that may help:

1. Stay hydrated: Drinking plenty of water helps flush out toxins from the bladder.
2. Increase fruit and vegetable intake: A diet rich in fruits and vegetables provides antioxidants that may help protect against cancer.
3. Limit processed meats: Reducing processed meat consumption may lower the risk of cancer progression.
4. Avoid smoking: Smoking is a major risk factor for bladder cancer, so quitting can significantly improve outcomes.
5. Maintain a healthy weight: Obesity is linked to worse cancer outcomes, so managing weight through diet and exercise is important.
6. Regular exercise: Physical activity can boost overall health and improve the body’s ability to fight cancer.
7. Manage stress: Stress management techniques, such as meditation or yoga, can improve mental well-being during cancer treatment.
8. Limit alcohol consumption: Reducing alcohol intake may lower the risk of cancer recurrence.
9. Incorporate turmeric: Turmeric contains curcumin, which has anti-inflammatory properties that may support cancer treatment.
10. Consume green tea: Green tea contains antioxidants that may help protect against cancer.

It’s important to consult with your healthcare provider before making any significant lifestyle changes, especially during cancer treatment. Telemedicine offers a convenient way to discuss these options with your doctor from the comfort of your home.

Living with Bladder Cancer: Tips for Better Quality of Life

Living with bladder cancer can be challenging, but there are steps you can take to improve your quality of life:

1. Stay informed: Understanding your diagnosis and treatment options can help you feel more in control of your health.
2. Follow your treatment plan: Adhering to prescribed treatments and attending follow-up appointments is crucial for managing bladder cancer.
3. Seek support: Joining a support group or talking to a counselor can help you cope with the emotional challenges of living with cancer.
4. Maintain a healthy lifestyle: Eating a balanced diet, exercising regularly, and managing stress can improve your overall well-being.
5. Communicate with your healthcare team: Don’t hesitate to reach out to your doctor if you have concerns or questions about your treatment. Telemedicine makes it easy to stay in touch with your healthcare provider without needing to visit the office in person.

Conclusion

Bladder cancer is a serious condition that requires prompt diagnosis and treatment. Early detection can significantly improve outcomes, and there are many treatment options available, ranging from surgery to chemotherapy and immunotherapy. Lifestyle changes, such as quitting smoking and maintaining a healthy diet, can also support your treatment and improve your overall health.

If you or a loved one is experiencing symptoms of bladder cancer, it’s important to seek medical help as soon as possible. Our telemedicine practice offers a convenient way to consult with a healthcare provider from the comfort of your home. Early diagnosis and treatment can make a significant difference in managing bladder cancer and improving your quality of life.

James Kingsley

Learn More